Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

FDA headquarters
News
FDA Issues Warning Highlighting Risks of Ketamine for Psychiatric Disorder Treatment
10/27/2023
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed the growing interest in compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders and warns clinicians considering their use.
The FDA has recently addressed...
10/27/2023
Psych Congress Network
schizophrenia treatment
News
TV-46000 Demonstrates Prolonged Schizophrenia Relapse Prevention, SHINE Study Finds
10/25/2023
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting...
10/25/2023
Psych Congress Network
Illustration two profiles with brains
News
Hospitalization Following Suicide Attempt May Benefit Some, but Individualized Approach Needed
10/25/2023
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may reduce the number of additional suicide attempts (SA) in the immediate aftermath of an SA, but not for other recent SAs or suicide ideation (SI) alone.
Psychiatric hospitalization may...
10/25/2023
Psych Congress Network

Advertisement

A doctor sits with a patient
News
Increased Risk of Schizophrenia in Patients With Substance Use-Related ED Visits
10/23/2023
Emergency department (ED) visits for substance use, both with and without psychosis, were associated with an increased risk of developing schizophrenia spectrum disorder within 3 years.
Emergency department (ED) visits for substance use, both with and without psychosis, were associated with an increased risk of developing schizophrenia spectrum disorder within 3 years.
Emergency department (ED) visits...
10/23/2023
Psych Congress Network
Steven R. Chan, MD, MBA.
Updates in Psychiatry
DEA Extends Temporary Telehealth Prescribing Rules but Long-Term Investment Needed, Expert Says
10/20/2023
The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) jointly announced on October 6 that telehealth prescribing flexibilities will continue through December 31, 2024.
The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) jointly announced on October 6 that telehealth prescribing flexibilities will continue through December 31, 2024.
The US Drug Enforcement...
10/20/2023
Psych Congress Network
stock medication
News
Pilot Study Finds Solriamfetol Beneficial for Adults With ADHD
10/19/2023
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug...
10/19/2023
Psych Congress Network

Advertisement

Researchers Identify Correlation Between Schizophrenia and Somatic Mutations
News
Researchers Identify Correlation Between Schizophrenia and Somatic Mutations
10/18/2023
A correlation between schizophrenia and somatic copy-number variants—a type of mutation that occurs early in development, but after genetic material is inherited—has been identified by Harvard Medical Institute researchers.
A correlation between schizophrenia and somatic copy-number variants—a type of mutation that occurs early in development, but after genetic material is inherited—has been identified by Harvard Medical Institute researchers.
A correlation between...
10/18/2023
Psych Congress Network
Sad neutral happy faces
News
Newly Approved MDD Drug Does Not Appear to Increase Risk of Sexual Dysfunction
10/18/2023
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug...
10/18/2023
Psych Congress Network
Boys with ADHD
Conference Coverage
ADHD Diagnosis, Recommended Therapy More Likely in Older Children, Boys
10/17/2023
In children and adolescents, older age and male gender were factors associated with receiving a diagnosis as well as recommended ADHD therapy, according to a poster presented at the Child Neurology Society Annual Meeting.
In children and adolescents, older age and male gender were factors associated with receiving a diagnosis as well as recommended ADHD therapy, according to a poster presented at the Child Neurology Society Annual Meeting.
In children and adolescents,...
10/17/2023
Psych Congress Network

Advertisement

News
Pediatric Mental Healthcare Patients’ Telehealth Use Remains Well Above Pre-Pandemic Levels
10/13/2023
Although in-person mental healthcare services returned to 75% of pre-pandemic levels by August 2022, telehealth usage for pediatric patients with commercial insurance was still 2300% higher than pre-pandemic, according to new research.
Although in-person mental healthcare services returned to 75% of pre-pandemic levels by August 2022, telehealth usage for pediatric patients with commercial insurance was still 2300% higher than pre-pandemic, according to new research.
Although in-person mental...
10/13/2023
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use